Effects of surgical excision and radiation on medulloblastoma cell invasiveness

Canadian Journal of Neurological Sciences

Volumn 36, Issue 5, 2009, Pages 631-637

  Ranger, Adrianna ^a   McDonald, Warren ^a   Bauman, Glenn S ^b   Del Maestro, Rolando ^c  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b LONDON REGIONAL CANCER PROGRAM   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN GEL;

ARTICLE; ASSAY; CANCER INVASION; CELL AGGREGATION; CELL INVASION; HUMAN; HUMAN CELL; IRRADIATION; MEDULLOBLASTOMA; PRIORITY JOURNAL; RADIOSENSITIVITY; STATISTICAL ANALYSIS; TREATMENT OUTCOME; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; CELLULAR STRUCTURES; DOSE-RESPONSE RELATIONSHIP, RADIATION; EXTRACELLULAR MATRIX; HUMANS; MEDULLOBLASTOMA; MODELS, BIOLOGICAL; NEOPLASM INVASIVENESS; NEOPLASM TRANSPLANTATION; RADIATION TOLERANCE; TIME FACTORS;

EID: 69549113052     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100008155     Document Type: Article

References (57)

1. Ang C, Hauerstock D, Guiot MC, Kasymjanova G, Roberge D, Kavan P, et al. Characteristics and outcomes of medulloblastoma in adults. Pediatr Blood Cancer. 2008; 51:603-607
2. Coulbois S, Civit T, Grignon Y, Taillandier L, Girard F, Marchal C, et al. [Adult medulloblastoma. Review of 22 patients] [Article in French]. Neurochirurgie. 2001; 47:6-12.
3. Giordana MT, Schiffer P, Lanotte M, Girardi P, Chio A. Epidemiology of adult medulloblastoma. Int J Cancer. 1999; 80:689-692
4. Farwell JR, Flannery JT. Adult occurrence of medulloblastoma. Acta Neurochir (Wien). 1987; 86:1-5.
5. Pobereskin L, Treip C. Adult medulloblastoma. J Neurol Neurosurg Psychiatry. 1986; 49:39-42.
6. Chan MY, Teo WY, Seow WT, Tan AM. Epidemiology, management and treatment outcome of medulloblastoma in Singapore. Ann Acad Med Singapore. 2007; 36:314-318 (Pubitemid 47121443)
7. Kadri H, Mawla AA, Murad L. Incidence of childhood brain tumors in Syria (1993-2002). Pediatr Neurosurg. 2005; 41:173-177
8. Feltbower RG, Picton S, Bridges LR, Crooks DA, Glaser AW, McKinney PA. Epidemiology of central nervous system tumors in children and young adults (0-29 years), Yorkshire, United Kingdom. Pediatr Hematol Oncol. 2004; 21:647-660
9. Lang O, Kondas O, Torok S, Hauser P, Bognar L, Schuler D. [Incidence of pediatric brain tumors in Hungary between 1989 and 1999] [Article in Hungarian]. Orv Hetil. 2002; 143:451-454
10. Agerlin N, Gjerris F, Brincker H, Haase J, Laursen H, Moller KA, et al. Childhood medulloblastoma in Denmark 1960-1984. A population-based retrospective study. Childs Nerv Syst. 1999; 15:29-36 (discussion 37).
11. Stiller CA, Bunch KJ. Brain and spinal tumours in children aged under two years: incidence and survival in Britain, 1971-1985. Br J Cancer. 1992; 18:S50-3.
12. Chi JG, Khang SK. Central nervous system tumors among Koreans - a statistical study on 697 cases. J Korean Med Sci. 1989; 4:77-90.
13. Alston RD, Newton R, Kelsey A, Newbould MJ, Birch JM, Lawson B, et al. Childhood medulloblastoma in northwest England 1954 to 1997: incidence and survival. Dev Med Child Neurol. 2003; 45:308-314
14. McNeil DE, Coté TR, Clegg L, Rorke LB. Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Surveillance Epidemiology and End Results. Med Pediatr Oncol. 2002; 39:190-194
15. Farinotti M, Ferrarini M, Solari A, Filippini G. Incidence and survival of childhood CNS tumours in the Region of Lombardy, Italy. Brain. 1998; 121:1429-1436
16. Roberts RO, Lynch CF, Jones MP, Hart MN. Medulloblastoma: a population-based study of 532 cases. J Neuropathol Exp Neurol. 1991; 50:134-144
17. Kopac S, Jereb B. Medulloblastoma in children 0-3 years old: forty years' experience in Slovenia. Pediatr Hematol Oncol. 2004; 21:17-21. (Pubitemid 38101406)
18. Rickert CH. Epidemiological features of brain tumors in the first 3 years of life. Childs Nerv Syst. 1998; 14:547-550
19. Kumar R, Tekkok IH, Jones RA. Intracranial tumours in the first 18 months of life. Childs Nerv Syst. 1990; 6:371-374
20. Janish W, Haas JF, Schreiber D, Gerlach H. Primary central nervous system tumors in stillborns and infants. Epidemiological considerations. J Neurooncol. 1984; 2:113-116 (Pubitemid 14050552)
21. Johannesen TB, Langmark F, Lote K. Cause of death and long-term survival in patients with neuro-epithelial brain tumours: a population-based study. Eur J Cancer. 2003; 39:2355-2363 (Pubitemid 37214860)
22. Di Rocco C, Iannelli A, Papacci F, Tamburrini G. Prognosis of medulloblastoma in infants. Childs Nerv Syst. 1997; 13:388-396
23. Koeller KK, Rushing EJ. From the archives of the AFIP: medulloblastoma: a comprehensive review with radiologic-pathologic correlation. Radiographics. 2003; 23:13-37.
24. Ayan I, Kebudi R, Bayindir C, Darendeliler E. Microscopic local leptomeningeal invasion at diagnosis of medulloblastoma. Int J Radiat Oncol Biol Phys. 1997; 39:461-466 (Pubitemid 27392514)
25. Laerum OD. Local spread of malignant neuroepithelial tumors. Acta Neurochir (Wien). 1997; 139:515-522
26. Mulhern RK, Merchant TE, Gajjar A, Reddick WE, Kun LE. Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol. 2004; 5:399-408. (Pubitemid 38878043)
27. Palmer SL, Reddick WE, Gajjar A. Understanding the cognitive impact on children who are treated for medulloblastoma. J Pediatr Psychol. 2007; 32:1040-1049 (Pubitemid 47622289)
28. Spiegler BJ, Bouffet E, Greenberg ML, Rutka JT, Mabbott DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol. 2004; 22:706-713 (Pubitemid 41095075)
29. Qiu D, Kwong DL, Chan GC, Leung LH, Khong PL. Diffusion tensor magnetic resonance imaging finding of discrepant fractional anisotropy between the frontal and parietal lobes after whole-brain irradiation in childhood medulloblastoma survivors: reflection of regional white matter radiosensitivity? Int J Radiat Oncol Biol Phys. 2007; 69:846-851
30. Abd El-Aal HH, Mokhtar MM, Habib EE, El-Kashef AT, Fahmy ES. Medulloblastoma: conventional radiation therapy in comparison to chemo radiation therapy in the post-operative treatment of high-risk patients. J Egypt Natl Canc Inst. 2005; 17:301-307
31. Maddrey AM, Bergeron JA, Lombardo ER, McDonald NK, Mulne AF, Barenberg PD, et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol. 2005; 72:245-253 (Pubitemid 40867408)
32. Murthy SN, Cohen ME. Pseudomigraine with prolonged aphasia in a child with cranial irradiation for medulloblastoma. J Child Neurol. 2002; 17:134-138
33. Walter AW, Mulhern RK, Gajjar A, Heideman RL, Reardon D, Sanford RA, et al. Survival and neurodevelopmental outcome of young children with medulloblastoma at St Jude Children's Research Hospital. J Clin Oncol. 1999; 17:3720-3728
34. Keles GE, Berger MS, Srinivasin J, Kolstoe DD, Bobola MS, Silber JR. Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol Res. 1995; 7:493-503.
35. Tamaki M, McDonald W, Amberger V, Moore E, DelMaestro R. Implantation of C6 astrocytoma cells into collagen type I gels: invasive, proliferative and enzymatic characterizations. J Neurosurg. 1997; 87:602-609 (Pubitemid 27430404)
36. Paulino AC, Cha DT, Barker JL Jr, Lo S, Manera RB. Patterns of failure in relation to radiotherapy fields in supratentorial primitive neuroectodermal tumor. Int J Radiat Oncol Biol Phys. 2004; 58:1171-1176 (Pubitemid 38314802)
37. Halperin EC. Impact of radiation technique upon the outcome of treatment for medulloblastoma. Int J Radiat Oncol Biol Phys. 1996; 36:233-239 (Pubitemid 26314171)
38. Van Someren EJ, Swart-Heikens J, Endert E, Bisschop PH, Swaab DF, Bakker PJ, et al. Long-term effects of cranial irradiation for childhood malignancy on sleep in adulthood. Eur J Endocrinol. 2004; 150:503-510 (Pubitemid 38584701)
39. Lew SM, Morgan JN, Psaty E, Lefton DR, Allen JC, Abbott R. Cumulative incidence of radiation-induced cavernomas in long-term survivors of medulloblastoma. J Neurosurg. 2006; 104:103-107 (Pubitemid 44968439)
40. Lee JK, Cherlvarajah R, King A, David KM. Rare presentations of delayed radiation injury: a lobar hematoma and a cystic space-occupying lesion appearing more than 15 years after cranial radiotherapy: report of two cases. Neurosurgery. 2004; 54:1010-1013 (discussion 1014). (Pubitemid 38437298)
41. Baumgartner JE, Ater JL, Ha CS, Kuttesch JF, Leeds NE, Fuller GN, et al. Pathologically proven cavernous angiomas of the brain following radiation therapy for pediatric brain tumors. Pediatr Neurosurg. 2003; 39:201-207
42. Reddick WE, Russell JM, Glass JO, Xiong X, Mulhern RK, Langston JW, et al. Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. Magn Reson Imaging. 2000; 18:787-793 (Pubitemid 30769058)
43. McMillan TJ. In vitro radiosensitivity of human medulloblastoma cell lines. J Neurooncol. 1993; 15:91-92
44. Salaroli R, Di Tomaso T, Ronchi A, Ceccarelli C, Cammelli S, Cappellini A, et al. Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin? J Neurooncol. 2008; 90:243-251
45. Lee YY, Kao CL, Tsai PH, Tsai TH, Chiou SH, Wu WF, et al. Caffeic acid phenethyl ester preferentially enhanced radiosensitizing and increased oxidative stress in medulloblastoma cell line. Childs Nerv Syst. 2008; 24:987-994
46. Meyer JJ, Marks LB, Halperin EC, Kirkpatrick JP. Kinetic modeling of tumor growth and dissemination in the craniospinal axis: implications for craniospinal irradiation. Radiat Oncol. 2006; 1:48.
47. Ozawa T, Lu RM, Hu LJ, Lamborn KR, Prados MD, Deen DF. Radiopotentiation of human brain tumor cells by sodium phenylacetate. Cancer Lett. 1999; 142:139-146 (Pubitemid 29304569)
48. Powell SN, McMillan TJ, Steel GG. In vitro radiosensitivity of human medulloblastoma cell lines. J Neurooncol. 1993; 15:91-92
49. Blazek ER, Foutch JL, Maki G. Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia. Int J Radiat Oncol Biol Phys. 2007; 67:1-5. (Pubitemid 44959518)
50. Tsuboi K, Tsuchida Y, Endo K, Yoshii Y, Nose T. Isolation of radiosensitive and radioresistant mutants from a medulloblastoma cell line. Brain Tumor Pathol. 1997; 14:19-25.
51. Pfister S, Remke M, Benner A, Mendryzk F, Toedt G, Felsberg J, et al. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J Clin Oncol. 2009; 27:1627-1636
52. de Haas T, Hasselt N, Troost D, Caron H, Popovic M, Zadravec-Zaletel L, et al. Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression. Clin Cancer Res. 2008; 14:4154-4160
53. Sanson M, Laigle-Donadey F, Benouaich-Amiel A. Molecular changes in brain tumors: prognostic and therapeutic impact. Curr Opin Oncol. 2006; 18:623-630 (Pubitemid 44427638)
54. Min HS, Lee YJ, Park K, Cho BK, Park SH. Medulloblastoma: histopathologic and molecular markers of anaplasia and biologic behavior. Acta Neuropathol. 2006; 112:13-20. (Pubitemid 43942158)
55. Mendryzk F, Radlwimmer B, Joos S, Kokocinski F, Benner A, Strange DE, et al. Genomic and protein expression profiling identifies CDK6 as novel independent prognostic marker in medulloblastoma. J Clin Oncol. 2005; 23:8853-8862 (Pubitemid 46211532)
56. Eberhart CG, Kratz J, Wang Y, Summers K, Stearns D, Cohen K, et al. Histopathological and molecular prognostic markers in medulloblastoma: c-myc, N-myc, TrkC, and anaplasia. J Neuropathol Exp Neurol. 2004; 63:441-449 (Pubitemid 38669665)
57. Neben K, Korshunov A, Benner A, Wrobel G, Hahn M, Kokocinski F, et al. Microarray-based screening for molecular markers in medulloblastoma revealed STK15 as independent predictor for survival. Cancer Res. 2004; 64:3103-3111 (Pubitemid 38581410)